Sun Pharma to Acquire InSite Vision
Sun Pharma has announced its one of the subsidiary entering into an agreement and plan of merger with InSite Vision […]
Tags: bacterial eye infections, Besifloxacin, BSE Sensex, Business/Finance, CEO, Chemistry, Cyclopropanes, drug delivery technology, DuraSite, DuraSite platform, health, Health/Medical/Pharmaceuticals, Insite, INSITE VISION INCORPORATED, Jerry St. Peter, Kal Sundaram, Latanoprost, M&A, ophthalmic products, ophthalmic solution, Organic chemistry, Organochlorides, owned subsidiary, Sun Pharmaceutical, SUN PHARMACEUTICAL INDUSTRIES LIMITED, United States, USD, Vice President and Head
Genpact Re-defines Patient Care at Major Hospitals in New Delhi
Genpact, a leader in managing business processes, announced the successful implementation of two pilot projects using the Hospital Operating System based on its proprietary Smart Enterprise Processes (SEPSM) methodology for New Delhi based Lok Nayak Hospital and Dr. Ram Manohar Lohia Hospital respectively.
